Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 4/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.44 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.44 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.44 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8909 | 0.97 | TRPV1 (0.50) | TRPV1CA1CA2CA5ACA9 | |
| SCHEMBL16626116 | 0.89 | TRPV1 (0.46) | TRPV1CA1CA2CA5ACA9 | |
| SCHEMBL2841466 | 0.89 | KIF11 (0.61) | TRPV1CA1CA2CA5ACA9 | |
| Bromobenzene SCHEMBL28432577 | 0.87 | ALDH1A1 (0.62) | TRPV1CA1CA2CA5ACA9 | |
| SCHEMBL25011793 | 0.83 | TRPV1 (0.42) | TRPV1CA1CA2CA5ACA9 | |
| SCHEMBL5982635 | 0.83 | GLB1 (0.52) | TRPV1CA1CA2CA5ACA9 | |
| SCHEMBL9262733 | 0.83 | SLC6A4 (0.53) | TRPV1CA1CA2CA5ACA9 | |
| Formic Acid SCHEMBL31514292 | 0.83 | CES2 (0.46) | TRPV1CA1CA2CA5ACA9 | |
| SCHEMBL8617788 | 0.83 | KIF11 (0.47) | TRPV1CA1CA2CA5ACA9 | |
| SCHEMBL27289737 | 0.83 | CA1 (0.55) | TRPV1CA1CA2CA5ACA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118908996-A | A composition containing C (sp2) P bond or C (sp)3) Process for preparing organic phosphine compound of-P bond | 烟台大学 | 2024-11-08 | — | — | CN | claimed |
| CN-119798292-A | Polycyclic fusion molecule containing oxygen, boron and nitrogen coordination bonds and preparation method thereof | 华侨大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-118206440-A | Efficient and convenient preparation method of diaryl ketone | 中南民族大学 | 2024-06-18 | — | — | CN | disclosed |
| CN-117567511-A | Complex, complex catalyst, and preparation method and application thereof | 合肥中科科乐新材料有限责任公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-117043165-A | Metal coordinating photoactive compounds for transparent photovoltaic devices | 无处不在能量公司 | 2023-11-10 | — | — | CN | disclosed |
| US-11453677-B2 | Tricyclic compounds useful to treat orthomyxovirus infections | NOVARTIS AG (CH) | 2022-09-27 | — | — | US | disclosed |
| US-11066422-B2 | Method of producing cycloalkyl(trifluoromethyl)benzene | TORAY FINE CHEMICALS CO., LTD. (JP) | 2021-07-20 | — | — | US | disclosed |
| CN-109096088-B | Process for preparing fused ring indeno compounds | 光学转变公司 | 2021-04-30 | — | — | CN | disclosed |
| US-20210053992-A1 | METHOD OF PRODUCING CYCLOALKYL(TRIFLUOROMETHYL)BENZENE | TORAY FINE CHEMICALS CO., LTD. (JP) | 2021-02-25 | — | — | US | disclosed |
| US-10858366-B2 | Tricyclic compounds useful to treat orthomyxovirus infections | NOVARTIS AG (CH) | 2020-12-08 | — | — | US | disclosed |
| WO-1998045263-A1 | ANALOGS OF COCAINE | GEORGETOWN UNIVERSITY (US) | 1998-10-15 | — | — | WO | disclosed |
| US-5795901-A | Insecticidal N-(substituted arylmethyl)-4- bis(substituted aryl)hydroxymethyl!piperidinium salts | FMC CORPORATION (US) | 1998-08-18 | — | — | US | disclosed |
| WO-1998000015-A1 | INSECTICIDAL N-(SUBSTITUTED ARYLMETHYL)-4-[BIS(SUBSTITUTED ARYL) HYDROXYMETHYL]PIPERIDINIUM SALTS | FMC CORPORATION (US) | 1998-01-08 | — | — | WO | disclosed |
| US-5182381-A | Intermediates for 3-keto-19-nor-Δ4,9 -steroids | ROUSSEL ULCAF (FR) | 1993-01-26 | — | — | US | disclosed |
| US-5064822-A | Antiglucocorticoid | ROUSSEL UCLAF (FR) | 1991-11-12 | — | — | US | disclosed |
| US-4540686-A | ANTIPROGESTERONES | ROUSSEL UCLAF (FR) | 1985-09-10 | — | — | US | disclosed |
| US-4477445-A | ANTIGLUCOCORTICOIDS | ROUSSEL UCLAF (FR) | 1984-10-16 | — | — | US | disclosed |
| US-4387230-A | Process for preparing a dihydropyridine derivative | JOHN WYETH AND BROTHER LIMITED (GB) | 1983-06-07 | — | — | US | disclosed |
| US-4265907-A | Insecticidal hydroxylamine ethers | MOBIL OIL CORPORATION (US) | 1981-05-05 | — | — | US | disclosed |
| US-4105849-A | [(Substituted )phenyl]phenylmethyl-1-(dialkylaminoalkyl)piperidines | G. D. SEARLE & CO. (US) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10858366-B2 | Tricyclic compounds useful to treat orthomyxovirus infections | ZC3HAV1, OTC, THOP1 | TRPV1 310/4885CA1 3547/4885CA2 1005/4885 |
| US-11066422-B2 | Method of producing cycloalkyl(trifluoromethyl)benzene | HCN4, MAP2K4, GRHPR | TRPV1 782/4885CA1 844/4885CA2 51/4885 |
| US-20210053992-A1 | METHOD OF PRODUCING CYCLOALKYL(TRIFLUOROMETHYL)BENZENE | HCN4, MAP2K4, GRHPR | TRPV1 782/4885CA1 844/4885CA2 51/4885 |
| US-11453677-B2 | Tricyclic compounds useful to treat orthomyxovirus infections | ZC3HAV1, OTC, THOP1 | TRPV1 295/4885CA1 3067/4885CA2 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.